<div>Hi,
</div>
<div>A heartfelt Thank you for reading our story
</div>
<div>We are a family from Surrey.
</div>
<div>About Gurmoh
</div>
<div>Gurmoh is a joyful 3-year-old who attends preschool, loves making friends, and connects easily with both children and adults. His favorite song is Wheels on the Bus, and he happily dances to Baby Shark. He dreams of becoming a firefighter and spends his days driving his toy fire truck around the house, proudly wearing his hat.
</div>
<div>⸻
</div>
<div>Medical Condition
</div>
<div>Gurmoh has a gait abnormality and struggles with balance on uneven surfaces. He has been diagnosed with a rare, progressive neurodegenerative disease—Spastic Paraplegia (SPAST c.1496 G&gt;A), caused by a de novo mutation (neither parent carries it).
</div>
<div><br />
</div>
<div>This condition progressively damages the nerves responsible for movement and cognition. It leads to painful muscle stiffness and, over time, paralysis of the legs and trunk.
</div>
<div>⸻
</div>
<div>What This Means for His Future
</div>
<div><br />
</div>
<div>Without timely gene therapy, Gurmoh is expected to lose his ability to walk, eat, speak, and eventually his independence. He may also experience severe pain and cognitive decline.
</div>
<div><br />
</div>
<div>Today, he remains independent, with challenges mainly on stairs and uneven ground.
</div>
<div>⸻
</div>
<div>Why There Is No Treatment Yet
</div>
<div><br />
</div>
<div>There is currently no approved therapy. Due to the rarity of his condition and lack of funding for rare disease treatment from government and pharmaceutical companies 
</div>
<div>⸻
</div>
<div>A Real Path Forward
</div>
<div>Gene therapy has already been successfully developed for similar conditions, such as SPG50, demonstrating that treatment is possible. Innovative rare disease medicine is life changing for these children from from rare diseases 
</div>
<div><br />
</div>
<div>McGill University has committed in writing to develop a gene therapy for Gurmoh, led by Dr. Ziv Gan-Or, Director of Clinical Research at The Neuro. This gives him a critical window of hope before further progression. This gene therapy could be used for other kids with same condition and will open the door for many more.
</div>
<div>Each and every dollar will go into developing this gene therapy.
</div>
<div>⸻
</div>
<div>Financial Challenge and why we need help
</div>
<div><br />
</div>
<div>The estimated cost to develop and deliver this therapy is $6–8 million, covering research, pre-clinical, and clinical phases. Early stages depend heavily on patient and philanthropic funding, while later stages may receive government support.
</div>
<div>We cannot do this alone. We are giving everything we can to this but it’s not possible without your support. Each and every dollar and share makes a huge difference for us
</div>
<div><br />
</div>
<div>Gurmoh’s ongoing care costs us approximately $6,000–$8,000 per month, including therapies, specialized equipment, and frequent travel for intensive treatment. After this one time gene therapy treatment he will be cured of this disease and could lead a normal life.
</div>
<div>⸻
</div>
<div>Time is critical
</div>
<div><br />
</div>
<div>Gurmoh needs $2.7 million to initiate and accelerate the development of his gene therapy. The science, expertise, and infrastructure are already in place at McGill—funding will determine how quickly treatment can reach him. Every second his nerves are dying because of this disease and they cannot be recovered back. He needs the treatment as soon as possible. If the funding doesn’t come in time it will not be possible to save him from this disease
</div>
<div>⸻
</div>
<div>Message from our family
</div>
<div><br />
</div>
<div>Like any child, Gurmoh deserves a happy, pain-free, and independent life. He is not asking for anything extraordinary—just the chance to live like every other child.
</div>
<div>With your help, his story doesn’t have to be one of loss— it can be one of hope, strength, and a brighter future.
</div>
<div>From our family to yours, thank you for listening—and for standing with Gurmoh
</div>
<div><br />
</div>
<div>Time is critical. Every moment matters.
</div>
<div><br />
</div>
<div>For more information visit
</div>
<div><a href="https://spg4hope.org/" target="_blank" rel="noreferrer noopener"><a href="https://spg4hope.org/" target="_blank" class="" rel="nofollow noopener noreferrer">https://spg4hope.org/</a></a>
</div>
<div><br />
</div>
<div>Social media
</div>
<div>Instagram
</div>
<div><a href="https://www.instagram.com/spg4hopefoundation_gurmoh?igsh=eTh4ZmtkeGpjNWZr" target="_blank" rel="noreferrer noopener"><a href="https://www.instagram.com/spg4hopefoundation_gurmoh?igsh=eTh4ZmtkeGpjNWZr" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.instagram.com/spg4hopefoundation_gurmoh?igsh=eTh4ZmtkeGpjNWZr</a></a>
</div>
<div><br />
</div>
<div>Facebook
</div>
<div><a href="https://www.facebook.com/share/1CUxJ2D2wT/" target="_blank" rel="noreferrer noopener"><a href="https://www.facebook.com/share/1CUxJ2D2wT/" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.facebook.com/share/1CUxJ2D2wT/</a></a>
</div>
<div><br />
</div>
<div>Tik tok
</div>
<div><a href="https://www.tiktok.com/" target="_blank" rel="noreferrer noopener"><a href="https://www.tiktok.com/" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.tiktok.com/</a></a>@spg4hopefoundation?_r=1&amp;_t=ZS-95Pj0O2SMau
</div>
<div><br />
</div>
<div>Media
</div>
<div><br />
</div>
<div><a href="https://globalnews.ca/news/11770263/bc-family-gene-therapy-son-rare-condition/" target="_blank" rel="noreferrer noopener"><a href="https://globalnews.ca/news/11770263/bc-family-gene-therapy-son-rare-condition/" target="_blank" class="" rel="nofollow noopener noreferrer">https://globalnews.ca/news/11770263/bc-family-gene-therapy-son-rare-condition/</a></a>
</div>
<div><br />
</div>
<div><a href="https://www.ctvnews.ca/vancouver/article/high-tech-health-care-only-for-the-ultra-rich-bc-toddlers-case-spotlights-inequality-of-gene-therapy/" target="_blank" rel="noreferrer noopener"><a href="https://www.ctvnews.ca/vancouver/article/high-tech-health-care-only-for-the-ultra-rich-bc-toddlers-case-spotlights-inequality-of-gene-therapy/" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.ctvnews.ca/vancouver/article/high-tech-health-care-only-for-the-ultra-rich-bc-toddlers-case-spotlights-inequality-of-gene-therapy/</a></a>
</div>
<div><br />
</div>
<div><a href="https://www.cbc.ca/player/play/video/9.7160283" target="_blank" rel="noreferrer noopener"><a href="https://www.cbc.ca/player/play/video/9.7160283" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.cbc.ca/player/play/video/9.7160283</a></a>
</div>
<div><br />
</div>
<div><a href="https://www.msn.com/en-ca/news/canada/bc-says-it-can-t-fund-therapy-for-child-with-rare-neurological-disease/vi-AA20CQwg" target="_blank" rel="noreferrer noopener"><a href="https://www.msn.com/en-ca/news/canada/bc-says-it-can-t-fund-therapy-for-child-with-rare-neurological-disease/vi-AA20CQwg" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.msn.com/en-ca/news/canada/bc-says-it-can-t-fund-therapy-for-child-with-rare-neurological-disease/vi-AA20CQwg</a></a>
</div>
<div><br />
</div>
<div><a href="https://vancouver.citynews.ca/2026/04/17/surrey-child-rare-disease-academics/" target="_blank" rel="noreferrer noopener"><a href="https://vancouver.citynews.ca/2026/04/17/surrey-child-rare-disease-academics/" target="_blank" class="" rel="nofollow noopener noreferrer">https://vancouver.citynews.ca/2026/04/17/surrey-child-rare-disease-academics/</a></a>
</div>
<div><br />
</div>

Markandi Sheoran

Anonymous

Vardan Gill

Damanjit Bhangoo

Harjit Kaur

Amrita Bhatia

Varinder singh

Kuljinder Chhaitra

Vitacore Health

Bharatpreet Singh Sandhu

Kahina Abdesselam

Bal Khabra

Nirmal Kaur

A Race Against Time to save our 3-year-old son Gurmoh

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

A Race Against Time to save our 3-year-old son Gurmoh

Still $954,125 to go. Help us build momentum.